Does statin use decrease the amount of Alzheimer disease pathology in the brain?
Silbert
Lisa C
LC
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000473:pathology* / Q000503:physiopathology; D001921:Brain / Q000187:drug effects* / Q000473:pathology* / Q000503:physiopathology; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D050356:Lipid Metabolism / Q000187:drug effects / Q000502:physiology; D016874:Neurofibrillary Tangles / Q000187:drug effects / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D058225:Plaque, Amyloid / Q000187:drug effects / Q000473:pathology; D016896:Treatment Outcome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018696:Neuroprotective Agents